ClinicalTrials.Veeva

Menu

Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure

N

National Center for Cardiovascular Diseases

Status

Enrolling

Conditions

End-stage Heart Failure
Congenital
Heart Failure

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06345521
2022-1-4032-3

Details and patient eligibility

About

Establish a follow-up management system for pediatric heart failure and a registration platform for end-stage heart failure

Enrollment

100 estimated patients

Sex

All

Ages

Under 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients younger than 14 years of age
  • refractory heart failure

Exclusion criteria

Trial design

100 participants in 1 patient group

End-Stage Heart Failure Group
Description:
Children with end-stage heart failure
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Zheng Dou, PhD; Kai Ma, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems